Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia

por Kminkova, Jana, Mraz, Marek, Zaprazna, Kristina, Navrkalova, Veronika, Tichy, Boris, Plevova, Karla, Malcikova, Jitka, Cerna, Katerina, Rausch, Tobias, Benes, Vladimir, Brychtova, Yvona, Doubek, Michael, Mayer, Jiri, Pospisilova, Sarka
Publicado 2014

Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells

por Zemanova, Jana, Hylse, Ondrej, Collakova, Jana, Vesely, Pavel, Oltova, Alexandra, Borsky, Marek, Zaprazna, Kristina, Kasparkova, Marie, Janovska, Pavlina, Verner, Jan, Kohoutek, Jiri, Dzimkova, Marta, Bryja, Vitezslav, Jaskova, Zuzana, Brychtova, Yvona, Paruch, Kamil, Trbusek, Martin
Publicado 2016

IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K(δ) inhibitor idelalisib

por Sandova, Veronika, Pavlasova, Gabriela Mladonicka, Seda, Vaclav, Cerna, Katerina Amruz, Sharma, Sonali, Palusova, Veronika, Brychtova, Yvona, Pospisilova, Sarka, Fernandes, Stacey M., Panovska, Anna, Doubek, Michael, Davids, Matthew S., Brown, Jennifer R., Mayer, Jiri, Mraz, Marek
Publicado 2021

Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes

por Olbertova, Helena, Plevova, Karla, Pavlova, Sarka, Malcikova, Jitka, Kotaskova, Jana, Stranska, Kamila, Spunarova, Michaela, Trbusek, Martin, Navrkalova, Veronika, Dvorackova, Barbara, Tom, Nikola, Pal, Karol, Jarosova, Marie, Brychtova, Yvona, Panovska, Anna, Doubek, Michael, Pospisilova, Sarka
Publicado 2022

Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks

por Mikulkova, Zuzana, Manukyan, Gayane, Turcsanyi, Peter, Kudelka, Milos, Urbanova, Renata, Savara, Jakub, Ochodkova, Eliska, Brychtova, Yvona, Molinsky, Jan, Simkovic, Martin, Starostka, David, Novak, Jan, Janca, Ondrej, Dihel, Martin, Ryznerova, Pavlina, Mohammad, Lekaa, Papajik, Tomas, Kriegova, Eva
Publicado 2021

Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells

por Boudny, Miroslav, Zemanova, Jana, Khirsariya, Prashant, Borsky, Marek, Verner, Jan, Cerna, Jana, Oltova, Alexandra, Seda, Vaclav, Mraz, Marek, Jaros, Josef, Jaskova, Zuzana, Spunarova, Michaela, Brychtova, Yvona, Soucek, Karel, Drapela, Stanislav, Kasparkova, Marie, Mayer, Jiri, Paruch, Kamil, Trbusek, Martin
Publicado 2019

Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene

por Poppova, Lucie, Pavlova, Sarka, Gonzalez, Beatriz, Kotaskova, Jana, Plevova, Karla, Dumbovic, Gabrijela, Janovska, Pavlina, Bystry, Vojtech, Panovska, Anna, Bezdekova, Lucie, Maslejova, Stanislava, Brychtova, Yvona, Doubek, Michael, Krzyzankova, Marcela, Borsky, Marek, Mayer, Jiri, Bryja, Vitezslav, Alonso, Sergio, Pospisilova, Sarka
Publicado 2022

Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options

por Malcikova, Jitka, Pavlova, Sarka, Kunt Vonkova, Barbara, Radova, Lenka, Plevova, Karla, Kotaskova, Jana, Pal, Karol, Dvorackova, Barbara, Zenatova, Marcela, Hynst, Jakub, Ondrouskova, Eva, Panovska, Anna, Brychtova, Yvona, Zavacka, Kristyna, Tichy, Boris, Tom, Nikola, Mayer, Jiri, Doubek, Michael, Pospisilova, Sarka
Publicado 2021

COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group

por Šimkovič, Martin, Turcsányi, Peter, Špaček, Martin, Mihályová, Jana, Ryznerová, Pavlína, Maco, Mária, Vodárek, Pavel, Écsiová, Dominika, Poul, Hynek, Móciková, Heidi, Zuchnická, Jana, Panovská, Anna, Lekaa, Mohammad, Oršulová, Martina, Prchlíková, Adéla, Stejskal, Lukáš, Mašlejová, Stanislava, Brychtová, Yvona, Bezděková, Lucie, Papajík, Tomáš, Lysák, Daniel, Trněný, Marek, Smolej, Lukáš, Doubek, Michael
Publicado 2023